Alafair Biosciences snags $525K funding

Sep 12, 2013
Austin Business Journal

Alafair Biosciences Inc. received $525,000 of a planned $650,000 funding

The Austin-based company collected the capital from three investors, according to a Wednesday filing with the U.S. Securities and Exchange Commission

Alafair Biosciences, which was founded in 2011 as Alafair Biotechnology, develops cross-linked polysaccharide hydrogel films to address the post-surgical complication of adhesion, or tethering between opposing tissue surfaces

CEO Daniel Peterson, an Austin-based neurosurgeon, was previously Brackenridge Hospital’s chief of staff, according to the company’s website

Last year, it received $702,000 of a planned $1.5 million financing from 14 investors, according to an SEC filing

Print Article opens in new window